HIGHBRIDGE CAPITAL MANAGEMENT LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 129 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2016$164,000
-83.2%
30,633
-82.8%
0.00%
-81.2%
Q2 2016$976,000
+162.4%
177,799
+255.0%
0.02%
+166.7%
Q1 2016$372,000
+18.8%
50,087
+43.9%
0.01%
+20.0%
Q3 2015$313,000
+347.1%
34,808
+129.3%
0.01%
+400.0%
Q1 2014$70,00015,1800.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2017
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders